Illustration of a money burning biotech lab

By Doug Young & Rene Vanguestaine

AstraZeneca has offered to buy money-losing Gracell Biotech for up to $1.2 billion, in a first-of-its kind M&A for a Chinese drug startup. Will China approve the deal? And e-commerce company East Buy’s CEO gets sacked under pressure from its top online salesman. How much power do such influencers wield at Chinese internet companies?

About China Inc

China Inc by Bamboo Works discusses the latest developments on Chinese companies listed in Hong Kong and the United States to drive informed decision-making for investors and others interested in this dynamic group of companies.

Subscribe to China Inc on your favorite app:

Apple Podcasts Spotify Google Podcasts

Recent Articles

Restaurant operator Jiumaojiu announced Thursday that it expects to report its net profit rose more than 800% to 450 million yuan or higher last year.

FAST NEWS: Jiumaojiu forecasts eightfold profit jump

The latest: Restaurant operator Jiumaojiu International Holdings Ltd. (9922.HK) announced Thursday that it expects to report its net profit rose more than 800% to 450 million yuan ($62.5 million) or higher last year.…
Lanvin revenue grows 1% in 2023

NEWS WRAP: Lanvin business stagnates in 2023

The unit of Chinese conglomerate Fosun reported its revenue rose just 1% last year as the global luxury goods market stalled    By Teri Yu Luxury fashion brand operator Lanvin…